Medications provide relief from everyday problems and ailments on a daily basis. However, some of them pose risks to consumers. We tell you what medicines these are.
Essential for preventing disease and preserving public health, drugs are an integral part of the daily life of the French to relieve pain and ailments. However, according to the review Prescribecertain drugs are to be banned in 2025, relays the Notre Temps site. Do you want to know what medications these are? Find out everything you need to know.
Medicines: everything about the 88 dangerous treatments to be banned in 2025
What drugs should be banned in 2025
According to the independent review Prescribe, 88 treatments at risk are to be banned in 2025. The review has in fact analyzed drugs studied between 2010 and 2024 that have a marketing authorization (MA). After analysis, 106 medicines distributed in Europe are considered non-essential and 88 are recognized more dangerous than useful. These include medications such as lumirelax, citalopram, oxomemazine, but also anti-inflammatories such as ketoprofen or medications such as zyban. In addition, you can consult this list to find out more about the drugs that are more dangerous than useful in 2024 according to the Prescrire magazine.
Why should these drugs be banned in 2025?
According to the medical journal Prescribethese drugs pose a danger to human health. The objective of the journal is to protect patients from disproportionate damage. Indeed, some of these treatments are likely to increase allergic reactions, mortality rates or adverse effects in patients such as drowsiness, drowsiness, heart problems, dry mouth or heart problems. Furthermore, the treatments called into question by the review have the particularity of presenting fewer benefits and more risks for patients.
What is the study in the journal Prescrire about?
The with presented by the journal concerns the study of follow-up evaluations, new indications, new pharmaceutical specialties, but also on the effectiveness and adverse effects of certain pharmaceutical products. So, Prescribe aims to provide caregivers and patients with up-to-date, clear, reliable and summary data on various pharmaceutical products. Its objective is to guarantee the quality and neutrality of the information provided to the public. Furthermore, the ambition of the journal is to provide a review of medications to be avoided in order to better treat patients and guarantee them quality care.
What are Prescrire’s recommendations regarding these medications?
The change of therapeutic solution
In the event of illness, alternatives presenting fewer risks exist. So, to treat excess cholesterol, Prescribe recommends avoiding medications from the fenofibrate family and fibrates bézafibrate which can cause skin reactions. Likewise, against hypertension, the review recommends against olmesartan and similar molecules which expose one to autoimmune hepatitis and enteropathy. In addition, the review specifies that antidepressants such as escitalopram and citalopram expose one to cardiovascular risks. However, in case of illness, certain medications should not be taken together, according to a recent scientific study.
L’abstinence
Faced with common disorders such as coughs, colds, nausea, headaches and stomach aches, medication is not always the ideal solution. For this reason, Prescribe recommends avoiding medicated clays, especially for children suffering from diarrhea due to their lead contamination. Likewise, in case of cough, the review recommends avoiding muscle relaxers sometimes responsible for skin damage and digestive disorders. Furthermore, certain medications should not be taken with coffee to avoid complications.
